analogous 发表于 2025-3-28 18:32:19

The Debate , Elective Lymph Node Dissection in Papillary Thyroid Carcinoma,roximately 40% of patients with tumours >1 cm will have central node compartment metastases that are clinically undetectable. The performance of a routine or prophylactic central node dissection ensures that clinically undetectable nodal metastases are resected. Information about nodal status can be

CRUDE 发表于 2025-3-28 19:39:49

The Debate , Elective Lymph Node Dissection in Papillary Thyroid Carcinoma,s practice results in improved survival and reduced rates of recurrence and prevents complications from avoiding future salvage surgery and that it streamlines treatment by selecting those patients most likely to benefit from adjuvant therapy. We go on to consider the morbidity of the procedure in t

glacial 发表于 2025-3-29 02:26:22

Differentiated Thyroid Cancer: Prognostic and Risk Assessment Systems, predicted outcome. The key prognostic variables include patient age, tumor size, presence of lymph node or distant metastases, invasive behavior of the tumor, and grade or histology of the tumor. In this chapter, each of these variables is discussed in depth. In addition all of the major staging sy

enfeeble 发表于 2025-3-29 03:22:52

Role of Radioactive Iodine for Remnant Ablation in Patients with Papillary Thyroid Cancer,ree decades. In our chapter, we consider the implications of the recently published American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid carcinoma (DTC) and hope to clarify for our readers where we currently stand on their Recommendati

偏狂症 发表于 2025-3-29 10:25:56

Considerations in Thyrotropin-Stimulating Hormone Suppression in Individuals with Differentiated Thal rate at 5 years of 97.9%. Most commonly, DTC is first treated primarily by surgical resection of either the total thyroid or partial thyroid. In patients who have undergone a total thyroidectomy, thyroxine replacement therapy will be required for the rest of their lives and may be required in tho

reject 发表于 2025-3-29 13:54:44

http://reply.papertrans.cn/63/6225/622481/622481_46.png

情感脆弱 发表于 2025-3-29 17:51:34

http://reply.papertrans.cn/63/6225/622481/622481_47.png

完成才能战胜 发表于 2025-3-29 23:24:49

http://reply.papertrans.cn/63/6225/622481/622481_48.png

依法逮捕 发表于 2025-3-30 02:37:33

Lymph Node Dissection for Differentiated Thyroid Cancer, anatomy of the neck and the frequency of nodal involvement in differentiated thyroid cancer and reviews the indications for lymphadenectomy, including the controversial utility of prophylactic nodal dissections. The chapter provides extensive details regarding the technical aspects of both central and lateral compartment lymph node dissections.

escalate 发表于 2025-3-30 05:10:38

Anne T. Mancino,Lawrence T. KimWritten by experts in the field.Provides a concise yet comprehensive summary of the field.Includes the most up-to-date scientific and clinical information
页: 1 2 3 4 [5] 6 7
查看完整版本: Titlebook: Management of Differentiated Thyroid Cancer; Anne T. Mancino,Lawrence T. Kim Book 2017 The Editor(s) (if applicable) and The Author(s) 201